TY - JOUR
T1 - Prediction model of acute kidney injury induced by cisplatin in older adults using a machine learning algorithm
AU - Okawa, Takaya
AU - Mizuno, Tomohiro
AU - Hanabusa, Shogo
AU - Ikeda, Takeshi
AU - Mizokami, Fumihiro
AU - Koseki, Takenao
AU - Takahashi, Kazuo
AU - Yuzawa, Yukio
AU - Tsuboi, Naotake
AU - Yamada, Shigeki
AU - Kameya, Yoshitaka
N1 - Publisher Copyright:
© 2022 Okawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2022/1
Y1 - 2022/1
N2 - Background Early detection and prediction of cisplatin-induced acute kidney injury (Cis-AKI) are essential for the management of patients on chemotherapy with cisplatin. This study aimed to evaluate the performance of a prediction model for Cis-AKI. Methods Japanese patients, who received cisplatin as the first-line chemotherapy at Fujita Health University Hospital, were enrolled in the study. The main metrics for evaluating the machine learning model were the area under the curve (AUC), accuracy, precision, recall, and F-measure. In addition, the rank of contribution as a predictive factor of Cis-AKI was determined by machine learning. Results A total of 1,014 and 226 patients were assigned to the development and validation data groups, respectively. The current prediction model showed the highest performance in patients 65 years old and above (AUC: 0.78, accuracy: 0.77, precision: 0.38, recall: 0.70, F-measure: 0.49). The maximum daily cisplatin dose and serum albumin levels contributed the most to the prediction of Cis-AKI. Conclusion Our prediction model for Cis-AKI performed effectively in older patients.
AB - Background Early detection and prediction of cisplatin-induced acute kidney injury (Cis-AKI) are essential for the management of patients on chemotherapy with cisplatin. This study aimed to evaluate the performance of a prediction model for Cis-AKI. Methods Japanese patients, who received cisplatin as the first-line chemotherapy at Fujita Health University Hospital, were enrolled in the study. The main metrics for evaluating the machine learning model were the area under the curve (AUC), accuracy, precision, recall, and F-measure. In addition, the rank of contribution as a predictive factor of Cis-AKI was determined by machine learning. Results A total of 1,014 and 226 patients were assigned to the development and validation data groups, respectively. The current prediction model showed the highest performance in patients 65 years old and above (AUC: 0.78, accuracy: 0.77, precision: 0.38, recall: 0.70, F-measure: 0.49). The maximum daily cisplatin dose and serum albumin levels contributed the most to the prediction of Cis-AKI. Conclusion Our prediction model for Cis-AKI performed effectively in older patients.
UR - http://www.scopus.com/inward/record.url?scp=85123654728&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123654728&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0262021
DO - 10.1371/journal.pone.0262021
M3 - Article
C2 - 35041690
AN - SCOPUS:85123654728
SN - 1932-6203
VL - 17
JO - PloS one
JF - PloS one
IS - 1 January
M1 - e0262021
ER -